SOTAC PHARMACEUTICALS
Back to Income Statement
|
SOTAC PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹4.28 Cr | ₹2.88 Cr | ₹2.88 Cr | ₹-2.37 Cr | ₹0.09 Cr |
What is the latest Consolidated Net Profit of SOTAC PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹4.28 Cr |
| Mar2024 | ₹2.88 Cr |
| Mar2023 | ₹2.88 Cr |
| Mar2022 | ₹-2.37 Cr |
| Mar2021 | ₹0.09 Cr |
How is Consolidated Net Profit of SOTAC PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.28 Cr | 48.65 | |
| Mar2024 | ₹2.88 Cr | 0.03 | |
| Mar2023 | ₹2.88 Cr | Positive | |
| Mar2022 | ₹-2.37 Cr | Negative | |
| Mar2021 | ₹0.09 Cr | - | |
Compare Consolidated Net Profit of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹111.0 Cr | -14.5% | -23% | -26.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -3.5% | -6.4% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,492.0 Cr | -5.8% | -1.6% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,013.0 Cr | 1.4% | 7% | 23.7% | Stock Analytics | |
| CIPLA | ₹112,922.0 Cr | -4.7% | -6.8% | -0.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,115.0 Cr | -2.8% | -8.1% | -11.1% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -14.5% |
-23% |
-26.1% |
| SENSEX | -0.7% |
-1.9% |
8% |
You may also like the below Video Courses